{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:13:50Z","timestamp":1791893630619,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"2024 Applied Basic Research Programs of Science and Technology Commission Foundation of Suzhou","award":["SYW2024150"],"award-info":[{"award-number":["SYW2024150"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute myocardial infarction (AMI) is the primary cause of cardiac mortality worldwide. However, myocardial ischemia-reperfusion injury (MIRI) following reperfusion therapy is common in AMI, causing myocardial damage and affecting the patient\u2019s prognosis. Presently, there are no effective treatments available for MIRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a comprehensive bioinformatics analysis using three GEO datasets on differentially expressed genes, including gene ontology (GO), pathway enrichment analyses, and protein-protein interaction (PPI) network analysis. Cytoscape and LASSO methods were employed to identify novel regulator genes for ischemia-reperfusion (I\/R). Notably, gene S100A9 was identified as a potential regulator of I\/R. Additionally, clinical sample datasets were analyzed to prove the expression and mechanism of S100A9 and its down genes in I\/R. The correlation of S100A9 with cardiac events was also examined to enhance the reliability of our results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 135 differential genes between the peripheral blood of 47 controls and 92 I\/R patients. S100A9 was distinguished as a novel regulator gene of I\/R with diagnostic potential. RT-qPCR test demonstrated significant upregulation of S100A9 in I\/R. We also verified that S100A9 expression strongly correlates with left ventricular ejection fraction (LVEF) and MIRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study confirms that S100A9 is a key regulator of I\/R progression and may participate in ischemia-reperfusion injury by upregulating RAGE \/NFKB-NLRP3 activation. Elevated S100A9 levels may serve as a marker for identifying high-risk MIRI patients, especially those with coronary artery no-reflow (CNR), who might benefit from targeted therapeutic interventions. Furthermore, Peripheral blood S100A9 in AMI represents a new therapeutic target for preventing MIRI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00397-5","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T06:02:20Z","timestamp":1741672940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of regulator gene and pathway in myocardial ischemia-reperfusion injury: a bioinformatics and biological validation study"],"prefix":"10.1186","volume":"162","author":[{"given":"Yanqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingbo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"10440","key":"397_CR1","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBDCD Collaborators","year":"2024","unstructured":"Collaborators GBDCD. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2100\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(24)00367-2.","journal-title":"Lancet"},{"key":"397_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2018.01.024","volume":"117","author":"S Cadenas","year":"2018","unstructured":"Cadenas S. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic Biol Med. 2018;117:76\u201389. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.01.024.","journal-title":"Free Radic Biol Med"},{"key":"397_CR3","doi-asserted-by":"publisher","unstructured":"Dridi H, Santulli G, Bahlouli L, Miotto MC, Weninger G, Marks AR. Mitochondrial calcium overload plays a causal role in oxidative stress in the failing heart. Biomolecules. 2023;13(9). https:\/\/doi.org\/10.3390\/biom13091409.","DOI":"10.3390\/biom13091409"},{"issue":"19","key":"397_CR4","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1161\/CIRCULATIONAHA.123.065390","volume":"149","author":"M Sun","year":"2024","unstructured":"Sun M, Mao S, Wu C, Zhao X, Guo C, Hu J, et al. Piezo1-Mediated neurogenic inflammatory cascade exacerbates ventricular remodeling after myocardial infarction. Circulation. 2024;149(19):1516\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.065390.","journal-title":"Circulation"},{"issue":"3","key":"397_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tem.2023.10.010","volume":"35","author":"Q Xiang","year":"2024","unstructured":"Xiang Q, Yi X, Zhu XH, Wei X, Jiang DS. Regulated cell death in myocardial ischemia-reperfusion injury. Trends Endocrinol Metab. 2024;35(3):219\u201334. https:\/\/doi.org\/10.1016\/j.tem.2023.10.010.","journal-title":"Trends Endocrinol Metab"},{"key":"397_CR6","doi-asserted-by":"publisher","unstructured":"Goetzman E, Gong Z, Rajasundaram D, Muzumdar I, Goodchild T, Lefer D, et al. Serum metabolomics reveals distinct profiles during ischemia and reperfusion in a Porcine model of myocardial ischemia-Reperfusion. Int J Mol Sci. 2022;23(12). https:\/\/doi.org\/10.3390\/ijms23126711.","DOI":"10.3390\/ijms23126711"},{"issue":"5","key":"397_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11(5):255\u201365. https:\/\/doi.org\/10.1038\/nrcardio.2014.28.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"397_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong T, Liu L, Jiang W, Zhou R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020;20(2):95\u2013112. https:\/\/doi.org\/10.1038\/s41577-019-0215-7.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"397_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1006\/jmbi.2001.5340","volume":"316","author":"H Itou","year":"2002","unstructured":"Itou H, Yao M, Fujita I, Watanabe N, Suzuki M, Nishihira J, et al. The crystal structure of human MRP14 (S100A9), a Ca(2+)-dependent regulator protein in inflammatory process. J Mol Biol. 2002;316(2):265\u201376. https:\/\/doi.org\/10.1006\/jmbi.2001.5340.","journal-title":"J Mol Biol"},{"key":"397_CR10","doi-asserted-by":"publisher","first-page":"105212","DOI":"10.1016\/j.phrs.2020.105212","volume":"161","author":"G Sreejit","year":"2020","unstructured":"Sreejit G, Abdel Latif A, Murphy AJ, Nagareddy PR. Emerging roles of neutrophil-borne S100A8\/A9 in cardiovascular inflammation. Pharmacol Res. 2020;161:105212. https:\/\/doi.org\/10.1016\/j.phrs.2020.105212.","journal-title":"Pharmacol Res"},{"issue":"1","key":"397_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer Immunogenomic analyses reveal Genotype-Immunophenotype relationships and predictors of response to checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019.","journal-title":"Cell Rep"},{"issue":"20","key":"397_CR12","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618\u201351. https:\/\/doi.org\/10.1161\/CIR.0000000000000617.","journal-title":"Circulation"},{"issue":"1","key":"397_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119(1):91\u2013112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303577.","journal-title":"Circ Res"},{"issue":"7","key":"397_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jacbts.2020.03.015","volume":"5","author":"RI Jaen","year":"2020","unstructured":"Jaen RI, Val-Blasco A, Prieto P, Gil-Fernandez M, Smani T, Lopez-Sendon JL, et al. Innate immune receptors, key actors in cardiovascular diseases. JACC Basic Transl Sci. 2020;5(7):735\u201349. https:\/\/doi.org\/10.1016\/j.jacbts.2020.03.015.","journal-title":"JACC Basic Transl Sci"},{"issue":"12","key":"397_CR15","doi-asserted-by":"publisher","first-page":"14410","DOI":"10.1096\/fj.201900115RR","volume":"33","author":"J Yang","year":"2019","unstructured":"Yang J, Zhang F, Shi H, Gao Y, Dong Z, Ma L, et al. Neutrophil-derived advanced glycation end products-Nepsilon-(carboxymethyl) lysine promotes RIP3-mediated myocardial necroptosis via RAGE and exacerbates myocardial ischemia\/reperfusion injury. FASEB J. 2019;33(12):14410\u201322. https:\/\/doi.org\/10.1096\/fj.201900115RR.","journal-title":"FASEB J"},{"key":"397_CR16","doi-asserted-by":"publisher","unstructured":"Matsushima S, Sadoshima J. Yin and Yang of NADPH oxidases in myocardial Ischemia-Reperfusion. Antioxid (Basel). 2022;11(6). https:\/\/doi.org\/10.3390\/antiox11061069.","DOI":"10.3390\/antiox11061069"},{"issue":"5","key":"397_CR17","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCRESAHA.120.315865","volume":"127","author":"G Marinkovic","year":"2020","unstructured":"Marinkovic G, Koenis DS, de Camp L, Jablonowski R, Graber N, de Waard V, et al. S100A9 links inflammation and repair in myocardial infarction. Circ Res. 2020;127(5):664\u201376. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.315865.","journal-title":"Circ Res"},{"issue":"3","key":"397_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cardiores.2003.10.011","volume":"61","author":"J Vinten-Johansen","year":"2004","unstructured":"Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 2004;61(3):481\u201397. https:\/\/doi.org\/10.1016\/j.cardiores.2003.10.011.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"397_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.scib.2024.02.003","volume":"69","author":"Y Dong","year":"2024","unstructured":"Dong Y, Kang Z, Zhang Z, Zhang Y, Zhou H, Liu Y, et al. Single-cell profile reveals the landscape of cardiac immunity and identifies a cardio-protective Ym-1(hi) neutrophil in myocardial ischemia-reperfusion injury. Sci Bull (Beijing). 2024;69(7):949\u201367. https:\/\/doi.org\/10.1016\/j.scib.2024.02.003.","journal-title":"Sci Bull (Beijing)"},{"issue":"5","key":"397_CR20","doi-asserted-by":"publisher","first-page":"H500","DOI":"10.1152\/ajpheart.00381.2014","volume":"308","author":"L Ge","year":"2015","unstructured":"Ge L, Zhou X, Ji WJ, Lu RY, Zhang Y, Zhang YD, et al. Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy. Am J Physiol Heart Circ Physiol. 2015;308(5):H500\u20139. https:\/\/doi.org\/10.1152\/ajpheart.00381.2014.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"397_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1089\/ars.2019.7928","volume":"33","author":"M El Kazzi","year":"2020","unstructured":"El Kazzi M, Rayner BS, Chami B, Dennis JM, Thomas SR, Witting PK. Neutrophil-Mediated cardiac damage after acute myocardial infarction: significance of defining a new target cell type for developing cardioprotective drugs. Antioxid Redox Signal. 2020;33(10):689\u2013712. https:\/\/doi.org\/10.1089\/ars.2019.7928.","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"397_CR22","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/cvr\/cvab302","volume":"118","author":"G Sreejit","year":"2022","unstructured":"Sreejit G, Johnson J, Jaggers RM, Dahdah A, Murphy AJ, Hanssen NMJ, et al. Neutrophils in cardiovascular disease: warmongers, peacemakers, or both? Cardiovasc Res. 2022;118(12):2596\u2013609. https:\/\/doi.org\/10.1093\/cvr\/cvab302.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"397_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/eurheartj\/ehw002","volume":"38","author":"M Horckmans","year":"2017","unstructured":"Horckmans M, Ring L, Duchene J, Santovito D, Schloss MJ, Drechsler M, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J. 2017;38(3):187\u201397. https:\/\/doi.org\/10.1093\/eurheartj\/ehw002.","journal-title":"Eur Heart J"},{"issue":"8","key":"397_CR24","doi-asserted-by":"publisher","first-page":"e13636","DOI":"10.1111\/cpr.13636","volume":"57","author":"F Chen","year":"2024","unstructured":"Chen F, He Z, Wang C, Si J, Chen Z, Guo Y. Advances in the study of S100A9 in cardiovascular diseases. Cell Prolif. 2024;57(8):e13636. https:\/\/doi.org\/10.1111\/cpr.13636.","journal-title":"Cell Prolif"},{"key":"397_CR25","doi-asserted-by":"publisher","unstructured":"Maas RR, Soukup K, Fournier N, Massara M, Galland S, Kornete M et al. The local microenvironment drives activation of neutrophils in human brain tumors. Cell. 2023;186(21):4546-66 e27. https:\/\/doi.org\/10.1016\/j.cell.2023.08.043","DOI":"10.1016\/j.cell.2023.08.043"},{"issue":"10","key":"397_CR26","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1111\/jcmm.16424","volume":"25","author":"S Guo","year":"2021","unstructured":"Guo S, Su Q, Wen J, Zhu K, Tan J, Fu Q, et al. S100A9 induces nucleus pulposus cell degeneration through activation of the NF-kappaB signaling pathway. J Cell Mol Med. 2021;25(10):4709\u201320. https:\/\/doi.org\/10.1111\/jcmm.16424.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"397_CR27","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.7150\/thno.91180","volume":"14","author":"S Shen","year":"2024","unstructured":"Shen S, Zhang M, Wang X, Liu Q, Su H, Sun B, et al. Single-cell RNA sequencing reveals S100a9(hi) macrophages promote the transition from acute inflammation to fibrotic remodeling after myocardial ischemia\u2013reperfusion. Theranostics. 2024;14(3):1241\u201359. https:\/\/doi.org\/10.7150\/thno.91180.","journal-title":"Theranostics"},{"issue":"12","key":"397_CR28","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1038\/s41590-023-01656-1","volume":"24","author":"M Pruenster","year":"2023","unstructured":"Pruenster M, Immler R, Roth J, Kuchler T, Bromberger T, Napoli M, et al. E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8\/S100A9 release from neutrophils via transient gasdermin D pore formation. Nat Immunol. 2023;24(12):2021\u201331. https:\/\/doi.org\/10.1038\/s41590-023-01656-1.","journal-title":"Nat Immunol"},{"issue":"9","key":"397_CR29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.118.039262","volume":"140","author":"Y Li","year":"2019","unstructured":"Li Y, Chen B, Yang X, Zhang C, Jiao Y, Li P, et al. S100a8\/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic\/reperfusion injury. Circulation. 2019;140(9):751\u201364. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.039262.","journal-title":"Circulation"},{"issue":"13","key":"397_CR30","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.119.043833","volume":"141","author":"G Sreejit","year":"2020","unstructured":"Sreejit G, Abdel-Latif A, Athmanathan B, Annabathula R, Dhyani A, Noothi SK, et al. Neutrophil-Derived S100A8\/A9 amplify granulopoiesis after myocardial infarction. Circulation. 2020;141(13):1080\u201394. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043833.","journal-title":"Circulation"},{"key":"397_CR31","doi-asserted-by":"publisher","unstructured":"Chen TJ, Yeh YT, Peng FS, Li AH, Wu SC. S100A8\/A9 enhances Immunomodulatory and Tissue-Repairing properties of human amniotic mesenchymal stem cells in myocardial Ischemia-Reperfusion injury. Int J Mol Sci. 2021;22(20). https:\/\/doi.org\/10.3390\/ijms222011175.","DOI":"10.3390\/ijms222011175"},{"issue":"32","key":"397_CR32","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/eurheartj\/ehz461","volume":"40","author":"G Marinkovic","year":"2019","unstructured":"Marinkovic G, Grauen Larsen H, Yndigegn T, Szabo IA, Mares RG, de Camp L, et al. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 Blockade improves cardiac function after myocardial infarction. Eur Heart J. 2019;40(32):2713\u201323. https:\/\/doi.org\/10.1093\/eurheartj\/ehz461.","journal-title":"Eur Heart J"},{"issue":"5","key":"397_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1540-8183.2010.00561.x","volume":"23","author":"SH Rezkalla","year":"2010","unstructured":"Rezkalla SH, Dharmashankar KC, Abdalrahman IB, Kloner RA. No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of Pharmacologic therapy. J Interv Cardiol. 2010;23(5):429\u201336. https:\/\/doi.org\/10.1111\/j.1540-8183.2010.00561.x.","journal-title":"J Interv Cardiol"},{"issue":"9","key":"397_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11883-018-0747-5","volume":"20","author":"A Karimianpour","year":"2018","unstructured":"Karimianpour A, Maran A. Advances in coronary No-Reflow Phenomenon-a contemporary review. Curr Atheroscler Rep. 2018;20(9):44. https:\/\/doi.org\/10.1007\/s11883-018-0747-5.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"397_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0002-9149(86)90976-8","volume":"57","author":"ER Bates","year":"1986","unstructured":"Bates ER, Krell MJ, Dean EN, O\u2019Neill WW, Vogel RA. Demonstration of the no-reflow phenomenon by digital coronary arteriography. Am J Cardiol. 1986;57(1):177\u20138. https:\/\/doi.org\/10.1016\/0002-9149(86)90976-8.","journal-title":"Am J Cardiol"},{"issue":"13","key":"397_CR36","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/eurheartj\/ehv484","volume":"37","author":"G Niccoli","year":"2016","unstructured":"Niccoli G, Scalone G, Lerman A, Crea F. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016;37(13):1024\u201333. https:\/\/doi.org\/10.1093\/eurheartj\/ehv484.","journal-title":"Eur Heart J"},{"key":"397_CR37","doi-asserted-by":"publisher","first-page":"104727","DOI":"10.1016\/j.ebiom.2023.104727","volume":"94","author":"O Demeulenaere","year":"2023","unstructured":"Demeulenaere O, Mateo P, Ferrera R, Chiaroni PM, Bize A, Dai J, et al. Assessment of coronary microcirculation alterations in a Porcine model of no-reflow using ultrasound localization microscopy: a proof of concept study. EBioMedicine. 2023;94:104727. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104727.","journal-title":"EBioMedicine"},{"issue":"10","key":"397_CR38","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.5603\/KP.a2016.0065","volume":"74","author":"Z Wang","year":"2016","unstructured":"Wang Z, Ren L, Liu N, Lei L, Ye H, Peng J. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Kardiol Pol. 2016;74(10):1160\u20136. https:\/\/doi.org\/10.5603\/KP.a2016.0065.","journal-title":"Kardiol Pol"},{"issue":"4","key":"397_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","volume":"54","author":"G Niccoli","year":"2009","unstructured":"Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009;54(4):281\u201392. https:\/\/doi.org\/10.1016\/j.jacc.2009.03.054.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"397_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jcin.2016.11.059","volume":"10","author":"SH Rezkalla","year":"2017","unstructured":"Rezkalla SH, Stankowski RV, Hanna J, Kloner RA. Management of No-Reflow phenomenon in the catheterization laboratory. JACC Cardiovasc Interv. 2017;10(3):215\u201323. https:\/\/doi.org\/10.1016\/j.jcin.2016.11.059.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00397-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00397-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00397-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:45:19Z","timestamp":1741848319000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00397-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00397-5","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed according to the Declaration of Helsinki. The Ethical Committee of Changshu NO.2 PEOPLE\u2019s Hospital approved the protocol, and subjects were enrolled after written informed consent (approval no: 2024-KY-SK09).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the subjects for the submission and publication of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}